(PharmaNewsWire.Com, July 03, 2017 ) Antiviral drugs are described as curative or disease controlling agents against viral infections. These drugs specifically attack viruses at different metabolic processes and alter the normal functioning of viral particles. From the past few years resistance is observed among viruses against different antiviral drugs with increasing diversity of viruses. This challenge leads to the evolution of broad spectrum antiviral drugs that specifically attack viruses at specified targets such as DNA Polymerase, NS3 Protease, & Reverse Transcriptase. These drugs are used to prevent or cure different viral infections such as HIV/AIDS, Hepatitis, influenza, and other viral infections.
The main driver which adds fuel to the market is increasing incidence rates of viral infections, such as according to World Health Organization, HIV/AIDS continues to be the major threat claiming more than 35 million lives so far. Globally, approximately 1.1 million lost their lives due to HIV in 2015. Approximately, 36.7 million people have been suffering from HIV in 2015. Furthermore, as late stage pipeline drugs are anticipated to hit the market, this further supports the antiviral drugs market growth
The factors affecting the Global Market for Antiviral Drugs Market, either positively or negatively are presented in the DROC analysis. Some of the factors discussed in this section are increase in public awareness, rise in healthcare expenditure, boost in Research and Development segment, emergence of life-threatening diseases, growing interest to support the development of novel antiviral drugs, existence of well-established supply chain, high cost involved in drug development, increase in demand for alternative medicines (naturopathy, homeopathy, and oriental medicines), growing resistance among viruses against different antiviral drugs causing difficulty in developing broad-spectrum anti-viral drugs, restricted trade policies, lack of incentivization, and side-effects of products (nausea, diarrhea, and behavioral changes). In addition, increasing incidence rates of viral infections is also fuelling the antiviral drugs market growth are also added.
For granular level understanding the Antiviral Drugs Market is segmented based on the following categories with Market Size Estimations and Y-o-Y Forecasts presented for each sub-segment.
The market has also been geographically segmented into North America, Europe, Asia-Pacific and the Middle-East and Africa. North America is expected to command the major market share of 34.0% in the global antiviral drugs market. Whereas, Asia-Pacific is projected to grow at the highest CAGR of 6.12% during forecast period 2016-2021.For more of regional analysis check out the following reports.
North America Antiviral Drugs Market
Europe Antiviral Drugs Market
Asia-Pacific Antiviral Drugs Market
Latin America Antiviral Drugs Market
Middle East and Africa Antiviral Drugs Market
The major companies dominating the global Antiviral Drugs market are Johnson & Johnson (USA), Novartis International AG (Switzerland), Roche Holding AG (Switzerland), Pfizer (USA), Merck and Co. Inc (USA), GlaxoSmithKline plc (United Kingdom), AstraZeneca AB (United Kingdom), Gilead Sciences (USA), and Abbott Laboratories (USA).
The Global Antiviral Drugs Market study offers the following deliverables:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is blooming
Segment-level analysis on basis of type, application, end-user along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that effect the global market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Pharmaceuticals Segment:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
